Hepcidine and Iron Deficiency in Critically Ill Patients

NACompletedINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

October 26, 2016

Study Completion Date

September 30, 2017

Conditions
AnemiaCritical IllnessHospitalized for 5 Days or More
Interventions
BIOLOGICAL

hepcidin

"In order to assess iron deficiency by innovative method (dosage of Hepcidin), an additional collection of blood will be done at day 0 (and weekly until Intensive Care Unit discharge) and at Day 15 after Intensive Care Unit discharge.~Treatement of Iron deficiency anaemia and anaemia of chronic disease using intravenous iron (± erythropoietin) will be encouraged (or not) according to hepcidin levels"

BIOLOGICAL

ferritin and transferrin saturation

"In order to assess iron deficiency by using usual biomarkers (ferritin and transferrin saturation), collection of blood will be done at day 0 (and weekly until Intensive Care Unit discharge) and at Day 15 after Intensive Care Unit discharge.~Treatement of Iron deficiency anaemia and anaemia of chronic disease using intravenous iron (± erythropoietin) will be encouraged (or not) according to ferritin levels."

Trial Locations (1)

49000

Department of Anesthesiology & Critical Care, Angers University Hospital, 4 rue larrey, Angers

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT02276690 - Hepcidine and Iron Deficiency in Critically Ill Patients | Biotech Hunter | Biotech Hunter